Hydrolytic Reactivity Trends among Potential Prodrugs of the O<sup>2</sup>-Glycosylated Diazeniumdiolate Family. Targeting Nitric Oxide to Macrophages for Antileishmanial Activity
Carlos A. Valdez(Frederick National Laboratory for Cancer Research), Larry K. Keefer(Unknown), Brett M. Showalter(Frederick National Laboratory for Cancer Research), Thomas Wilde(Frederick National Laboratory for Cancer Research), Jeffrey R. Deschamps(United States Naval Research Laboratory), Stefan El-Gayar(Frederick National Laboratory for Cancer Research), Joseph J. Barchi(Frederick National Laboratory for Cancer Research), Joseph E. Saavedra(Genesis Laboratories), Christian Bogdan(Friedrich-Alexander-Universität Erlangen-Nürnberg), Michael L. Citro(Genesis Laboratories), Damon A. Parrish(United States Naval Research Laboratory), Keith M. Davies(George Mason University), Ulrike Schleicher(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 41
Related Papers
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
“NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
|Methods in enzymology on CD-ROM/Methods in enzymology|1996|674
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
|Nature Immunology|2003|363
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
|Science Immunology|2022|280
Nitric Oxide-Releasing Polymers Containing the [N(O)NO]<sup>-</sup>Group
|Journal of Medicinal Chemistry|1996|207